Supplementary Table 2 from The HSP90 Inhibitor Ganetespib Synergizes with the MET Kinase Inhibitor Crizotinib in both Crizotinib-Sensitive and -Resistant MET-Driven Tumor Models
crossref（2023）
摘要
PDF file - 69K, Crizotinib and ganetespib synergistically reduce growth of wild-type and mutant MET-driven tumor xenografts.
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要